PMA vs IMRN Comparison

Ming Shing Group Holdings Ltd is a holding company engaged through its subsidiaries in wet trades works, including plastering, tile laying, brick laying, floor screeding and marble works. To a much lesser extent, it provides small-scale fitting out services, such as renovation works, and engages in trading of wines and spirits. Through its subsidiaries, it is mainly engaged in private sector projects in Hong Kong, involving private residential and commercial developments, while public sector projects mainly involve public residential developments, infrastructure and public facilities developments. The Company operates through two segments: Provision of Wet Trades Works and Trading of Wines and Spirits, with Trading of Wines and Spirits generating the maximum revenue.

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.